{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:43:38Z","timestamp":1792658618990,"version":"4.5.0"},"reference-count":11,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2015,8,20]],"date-time":"2015-08-20T00:00:00Z","timestamp":1440028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Assoc Provid AIDS Care"],"published-print":{"date-parts":[[2016,1]]},"abstract":"\n Background:<\/jats:title>\n One barrier to wider preexposure prophylaxis (PrEP) availability is uncertainty about the most appropriate providers and practice settings for offering PrEP.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n The authors conducted in-depth interviews with 30 clinicians\u2014primary care and HIV specialists\u2014in the New York City (NYC) region to explore issues related to PrEP rollout, including who should provide it and in what settings.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n A diverse group favored offering PrEP in non-HIV specialty settings in order to reach high-risk HIV-negative individuals. Yet, for each clinical skill or ancillary service deemed important for providing PrEP\u2014knowledge of the medications, ability to assess and counsel around sexual risk behavior, and ability to provide support for retention and medication adherence\u2014participants were divided in whether they thought primary care providers\/practices could achieve it. Five participants strongly favored providing PrEP in HIV care practices.<\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Although there may be multiple \u201chomes\u201d for PrEP, implementation research is needed to identify the most effective delivery approaches.<\/jats:p>\n <\/jats:sec>","DOI":"10.1177\/2325957415600798","type":"journal-article","created":{"date-parts":[[2015,8,20]],"date-time":"2015-08-20T22:24:19Z","timestamp":1440109459000},"page":"59-65","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":70,"title":["A Clinical Home for Preexposure Prophylaxis"],"prefix":"10.1177","volume":"15","author":[{"given":"Susie","family":"Hoffman","sequence":"first","affiliation":[{"name":"Division of Gender, Sexuality, and Health, New York State Psychiatric Institute and Columbia University, New York, NY, USA"},{"name":"Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Guidry","sequence":"additional","affiliation":[{"name":"Gay Men\u2019s Health Crisis (GMHC) and SAE & Associates, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate L.","family":"Collier","sequence":"additional","affiliation":[{"name":"Division of Gender, Sexuality, and Health, New York State Psychiatric Institute and Columbia University, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne E.","family":"Mantell","sequence":"additional","affiliation":[{"name":"Division of Gender, Sexuality, and Health, New York State Psychiatric Institute and Columbia University, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Boccher-Lattimore","sequence":"additional","affiliation":[{"name":"Division of Gender, Sexuality, and Health, New York State Psychiatric Institute and Columbia University, New York, NY, USA"},{"name":"Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Kaighobadi","sequence":"additional","affiliation":[{"name":"Visiting Assistant Professor of Psychology, Bard College, Annandale-on-Hudson, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo G. M.","family":"Sandfort","sequence":"additional","affiliation":[{"name":"Division of Gender, Sexuality, and Health, New York State Psychiatric Institute and Columbia University, New York, NY, USA"},{"name":"Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2015,8,20]]},"reference":[{"key":"bibr1-2325957415600798","unstructured":"Mera R, Rawlings M, Pechonkina A, Rooney J, Peschel T, Cheng A. Status of Truvada (TVD) for pre-exposure prophylaxis (PrEP) in the United States: an early drug utilization analysis. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy; Denver, CO2013. Web site. www.natap.org\/2013\/ICAAC\/ICAAC_18htm. Accessed March 10, 2015."},{"key":"bibr2-2325957415600798","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.17.4.19730"},{"key":"bibr3-2325957415600798","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2012.09.057"},{"key":"bibr4-2325957415600798","doi-asserted-by":"crossref","unstructured":"Underhill K, Operario D, Mimiaga MJ, Skeer MR, Mayer KH. Implementation science of pre-exposure prophylaxis: preparing for public use. Current HIV\/AIDS Reports. 2010;7(4):210\u2013219.","DOI":"10.1007\/s11904-010-0062-4"},{"key":"bibr5-2325957415600798","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040603"},{"key":"bibr6-2325957415600798","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-014-0839-3"},{"key":"bibr7-2325957415600798","unstructured":"McCormack S. Pragmatic Open-Label Randomised Trial of Preexposure Prophylaxis: The PROUD Study. Conference on Retroviruses and Opportunistic Infections; Seattle, WA, February 23-26, 2015. Web site. http:\/\/www.croiwebcasts.org\/console\/player\/25539?mediaType=slideVideo& Accessed March 10, 2015."},{"key":"bibr8-2325957415600798","unstructured":"Molina JM, Capitant C, Spire B, On Demand PrEP with Oral TDF\/FTC in MSM: Results of the ANRS Ipergay Trial. Conference on Retroviruses and Opportunistic Infections (CROI); Seattle, WA; February 23-26, 2015. Downloaded from Web site. www.croiwebcasts.org\/console\/player\/25540?mediaType=slideVideo& Accessed March 10, 2015."},{"key":"bibr9-2325957415600798","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001613"},{"key":"bibr10-2325957415600798","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2012.09.028"},{"key":"bibr11-2325957415600798","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2012.09.037"}],"container-title":["Journal of the International Association of Providers of AIDS Care (JIAPAC)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2325957415600798","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2325957415600798","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2325957415600798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:53:32Z","timestamp":1777503212000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2325957415600798"}},"subtitle":["Diverse Health Care Providers\u2019 Perspectives on the \u201cPurview Paradox\u201d"],"short-title":[],"issued":{"date-parts":[[2015,8,20]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1177\/2325957415600798"],"URL":"https:\/\/doi.org\/10.1177\/2325957415600798","relation":{},"ISSN":["2325-9582","2325-9582"],"issn-type":[{"value":"2325-9582","type":"print"},{"value":"2325-9582","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,20]]}}}